Matinas BioPharma Holdings Inc To Provide Corporate Update And 2022 Business Outlook Call Transcript
Welcome to the Matinas BioPharma Corporate Update and 2022 Business Outlook Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to Peter Vozzo, Investor Relations representative for Matinas BioPharma. You may begin.
Thank you, Daryl. Good morning, everyone, and thank you for joining the Matinas BioPharma Corporate Update and 2022 Business Outlook Conference Call.
Earlier this morning, we issued a press release containing these updates and outlook. The release is available on the Matinas BioPharma website under the Investors section.
Speaking on today's call will be Jerry Jabbour, Chief Executive Officer; Dr. Terri Matkovits, Chief Development Officer; and Dr. Terry Ferguson, Chief Medical Officer. We also have Dr. Raphael Mannino, Chief Scientific Officer; and Tom Hoover, Chief Business Officer, available to answer questions during our Q&A session.
At this time, I would like to remind our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
